Characterization of the novel HLA-A*33:220 allele by next-generation sequencing.
HLA-A*33:220
HLA
next-generation sequencing
novel allele
Journal
HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
revised:
04
07
2023
received:
03
07
2023
accepted:
07
07
2023
pubmed:
18
7
2023
medline:
18
7
2023
entrez:
18
7
2023
Statut:
ppublish
Résumé
HLA-A*33:220 differs from HLA-A*33:03:01:01 by one nucleotide substitution in codon 245 in exon 4.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
616-617Informations de copyright
© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Barker DJ, Maccari G, Georgiou X, et al. IPD-IMGT/HLA Database. Nucleic Acids Res. 2023;51:D1053-D1060.
Menezes Teles E, Oliveira D, Santos M, et al. pHLA3D: an online database of predicted three-dimensional structures of HLA molecules. Hum Immunol. 2019;80(10):834-841. doi:10.1016/j.humimm.2019.06.009
Savage P. Cancer immunotherapy therapeutic manipulation of the CD8-HLA class I interaction: potential and challenges. Int J Immunol Immunother. 2019;6:35. doi:10.23937/2378-3672/1410035
Salter RD, Norment AM, Chen BP, et al. Polymorphism in the alpha 3 domain of HLA-A molecules affects binding to CD8. Nature. 1989;338:345-347.
Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system. Tissue Antigens. 2010;75(4):291-455. doi:10.1111/j.1399-0039.2010.01466.x